Metabolic Disorders Gallery
Browse the list below for project imagery.
Acomplia (Rimonabant) - Investigational Agent for
Byetta - First-in-Class Incretin Mimetic
Cetilistat - Investigational Drug for Obesity
Exubera - Inhaled Insulin
Fablyn (Lasofoxifene) - Investigational SERM
Galida - Dual PPAR
Galvus (vildagliptin) - DPP-IV Inhibitor / Oral
Januvia - DPP-IV inhibitor for Type 2 Diabetes
Liraglutide - Next-Generation Antidiabetic Medication
Lorcaserin, Investigational Oral Anti-Obesity Drug
Oral-Lyn - Oral Insulin for Type 1 and 2 Diabetes
Peginesatide (Hematide) – For the Treatment of Anaemia Associated with Chronic Kidney Disease
Prolia (Denosumab) - Therapy for Prevention and Treatment of Osteoporosis
Saxagliptin – Treatment for Type 2 Diabetes
Taranabant
